Literature DB >> 33644653

Mechanical valve replacement without anticoagulation: a case report.

Yapeng Wang1, Min Lin1, Shenglin Ge1, Junbo Feng1.   

Abstract

BACKGROUND: For patients who undergo mechanical valve replacement, the greatest disadvantage is that they require long-term or permanent use of anticoagulant therapy to prevent thromboembolism. To date, mechanical valve replacement without anticoagulation has been published in the literature. CASE
SUMMARY: We present the case of a 75-year-old female who underwent mechanical mitral valve replacement (MVR) on mid-June, 2007. However, this patient had not been taking anticoagulant medication since she experienced warfarin overdose in the first month after the operation. She had been well without using any anticoagulation, and there were no complications of the mechanical valve. DISCUSSION: There was no thrombosis for such a long period of time because she suffered from FX deficiency. To the best of our knowledge, she may be the only patient who has been well without any anticoagulation since not taking warfarin 12 years ago.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  Anticoagulation; Case report; Factor X deficiency; Valve replacement

Year:  2021        PMID: 33644653      PMCID: PMC7898660          DOI: 10.1093/ehjcr/ytaa566

Source DB:  PubMed          Journal:  Eur Heart J Case Rep        ISSN: 2514-2119


  17 in total

1.  International normalized ratio for the guidance of warfarin treatment in elderly patients after cardiac valve replacement.

Authors:  Qing-Hua Ma; Jian-Hai Fang
Journal:  Exp Ther Med       Date:  2018-12-10       Impact factor: 2.447

2.  Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?

Authors:  Vishesh Kumar; Shawn Kelly; Amol Raizada; Jimmy Yee; Amornpol Anuwatworn; Adam Stys; Maria Stys
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

Review 3.  Factor X deficiency.

Authors:  Marzia Menegatti; Flora Peyvandi
Journal:  Semin Thromb Hemost       Date:  2009-07-13       Impact factor: 4.180

4.  Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  Jack Ansell; Jack Hirsh; Elaine Hylek; Alan Jacobson; Mark Crowther; Gualtiero Palareti
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

Review 5.  Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.

Authors:  S C Cannegieter; F R Rosendaal; E Briët
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

6.  Aortic valve replacement: a prospective randomized evaluation of mechanical versus biological valves in patients ages 55 to 70 years.

Authors:  Paolo Stassano; Luigi Di Tommaso; Mario Monaco; Francesco Iorio; Paolo Pepino; Nicola Spampinato; Carlo Vosa
Journal:  J Am Coll Cardiol       Date:  2009-11-10       Impact factor: 24.094

Review 7.  Antithrombotic management of patients with prosthetic heart valves: current evidence and future trends.

Authors:  Jack C J Sun; Michael J Davidson; Andre Lamy; John W Eikelboom
Journal:  Lancet       Date:  2009-08-15       Impact factor: 79.321

8.  Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.

Authors:  Deborah M Siegal; John T Curnutte; Stuart J Connolly; Genmin Lu; Pamela B Conley; Brian L Wiens; Vandana S Mathur; Janice Castillo; Michele D Bronson; Janet M Leeds; Florie A Mar; Alex Gold; Mark A Crowther
Journal:  N Engl J Med       Date:  2015-11-11       Impact factor: 91.245

9.  Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.

Authors:  Tom Parks; Mariana M Mirabel; Joseph Kado; Kathryn Auckland; Jaroslaw Nowak; Anna Rautanen; Alexander J Mentzer; Eloi Marijon; Xavier Jouven; Mai Ling Perman; Tuliana Cua; John K Kauwe; John B Allen; Henry Taylor; Kathryn J Robson; Charlotte M Deane; Andrew C Steer; Adrian V S Hill
Journal:  Nat Commun       Date:  2017-05-11       Impact factor: 14.919

10.  Anticoagulation in atrial fibrillation with factor X deficiency-A management dilemma.

Authors:  Jian Liang Tan; Kah Poh Loh; Danielle Fortuna; Arezoo Ghaneie
Journal:  Clin Case Rep       Date:  2018-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.